GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Natco Pharma Ltd (BOM:524816) » Definitions » Price-to-Free-Cash-Flow

Natco Pharma (BOM:524816) Price-to-Free-Cash-Flow : N/A (As of May. 28, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Natco Pharma Price-to-Free-Cash-Flow?

As of today (2024-05-28), Natco Pharma's share price is ₹1029.20. Natco Pharma's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00. Hence, Natco Pharma's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Natco Pharma's Price-to-Free-Cash-Flow or its related term are showing as below:

BOM:524816' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0   Med: 22.13   Max: 473.69
Current: 29.2

During the past 13 years, Natco Pharma's highest Price-to-Free-Cash-Flow Ratio was 473.69. The lowest was 0.00. And the median was 22.13.

BOM:524816's Price-to-Free-Cash-Flow is ranked worse than
56.67% of 517 companies
in the Drug Manufacturers industry
Industry Median: 23.44 vs BOM:524816: 29.20

Natco Pharma's Free Cash Flow per Share for the three months ended in Mar. 2024 was ₹0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₹0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 122.10% per year.

During the past 13 years, Natco Pharma's highest 3-Year average Free Cash Flow per Share Growth Rate was 122.10% per year. The lowest was -47.40% per year. And the median was 14.00% per year.


Natco Pharma Price-to-Free-Cash-Flow Historical Data

The historical data trend for Natco Pharma's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natco Pharma Price-to-Free-Cash-Flow Chart

Natco Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 157.34 340.69 - 15.99 20.03

Natco Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.99 - - - -

Competitive Comparison of Natco Pharma's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Natco Pharma's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Natco Pharma's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Natco Pharma's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Natco Pharma's Price-to-Free-Cash-Flow falls into.



Natco Pharma Price-to-Free-Cash-Flow Calculation

Natco Pharma's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1029.20/0
=N/A

Natco Pharma's Share Price of today is ₹1029.20.
Natco Pharma's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Natco Pharma  (BOM:524816) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Natco Pharma Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Natco Pharma's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Natco Pharma (BOM:524816) Business Description

Traded in Other Exchanges
Address
Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034
Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.

Natco Pharma (BOM:524816) Headlines

No Headlines